| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. URGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 153.2K | $6.99M | - | |
| Other | 119.8K | $5.46M | -10,000 | |
| Other | 52.9K | $2.41M | - | |
| Dir | 20.0K | $912.0K | - | |
| Dir | 20.0K | $912.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Schoenberg Mark58 | Chief Medical Officer | Sell | 10,000 | $40.00 | $400,000.00 | -7.7% | - | - | |
| Jun 22, 2026 | Schoenberg Mark58 | Chief Medical Officer | Sell | 10,000 | $35.01 | $350,100.00 | -7.2% | - | - | |
| Jun 8, 2026 | Schoenberg Mark58 | Chief Medical Officer | Sale+OE | 5,222 | $27.30 | $142,560.60 | -3.6% | - | - | |
| Feb 3, 2026 | Smith Jason Drew46 | General Counsel | Sale+OE | 7,479 | $19.69 | $147,261.51 | -4.5% | +15.0% | - | |
| Nov 19, 2025 | Schoenberg Mark58 | Chief Medical Officer | Sell | 10,000 | $25.00 | $250,000.00 | -6.7% | -18.5% | - | |
| Oct 8, 2025 | Degnan Chris | Chief Financial Officer | Sale+OE | 2,203 | $16.85 | $37,120.55 | -49.1% | +26.3% | - | |
| Sep 8, 2025 | Schoenberg Mark58 | Chief Medical Officer | Sale+OE | 871 | $19.11 | $16,644.81 | -0.6% | +7.7% | - | |
| Sep 8, 2025 | Smith Jason Drew46 | General Counsel | Sale+OE | 1,520 | $19.11 | $29,047.20 | -3.4% | +7.7% | - | |
| Aug 11, 2025 | Schoenberg Mark58 | Chief Medical Officer | Sell | 10,000 | $17.69 | $176,900.00 | -6.3% | +26.8% | - | |
| Jul 28, 2025 | Smith Jason Drew46 | General Counsel | Sale+OE | 7,522 | $19.14 | $143,971.08 | -15.3% | +10.3% | +116.3% |